Leucovorin Calcium 350mg Inj, 1vl

Manufacturer HIKMA Active Ingredient Leucovorin Injection(loo koe VOR in) Pronunciation loo-koe-VOR-in
It is used with methotrexate to avoid side effects.It may lower the side effects of some drugs.It is used with fluorouracil to help fight colorectal cancer.It is used to help with some kinds of anemia.It may be given to you for other reasons. Talk with the doctor.
๐Ÿท๏ธ
Drug Class
Antidote; Antineoplastic Adjuvant; Hematopoietic Agent
๐Ÿงฌ
Pharmacologic Class
Folic Acid Analog; Folinic Acid
๐Ÿคฐ
Pregnancy Category
Category C
โœ…
FDA Approved
Mar 1953
โš–๏ธ
DEA Schedule
Not Controlled

Overview

โ„น๏ธ

What is this medicine?

Leucovorin is a type of vitamin (folic acid) that helps protect healthy cells from the harmful effects of certain cancer medicines, like methotrexate. It can also make other cancer medicines, like fluorouracil, work better against cancer cells. Sometimes, it's used to treat certain types of anemia.
๐Ÿ“‹

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and read all accompanying information carefully. Take this medication exactly as directed, and be sure to follow all instructions provided. This medication is administered via injection into a muscle or vein.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

If you miss a dose, contact your doctor immediately to receive guidance on what to do next.
๐Ÿ’ก

Lifestyle & Tips

  • Maintain good hydration, especially if receiving high-dose methotrexate.
  • Report any side effects promptly to your healthcare team.
  • Follow all instructions regarding diet and medication timing.

Dosing & Administration

๐Ÿ‘จโ€โš•๏ธ

Adult Dosing

Standard Dose: Highly variable based on indication. Examples: Methotrexate rescue: 10-15 mg/m2 IV/IM/PO every 6 hours for 10 doses, starting 24 hours after methotrexate. Fluorouracil modulation: 200 mg/m2 IV over 2 hours, followed by fluorouracil. Megaloblastic anemia: 1 mg/day IM/IV/PO.
Dose Range: 1 - 500 mg

Condition-Specific Dosing:

Methotrexate Rescue (High-Dose MTX): 10-15 mg/m2 IV/IM/PO every 6 hours for 10 doses, starting 24 hours after methotrexate. Dose and duration adjusted based on methotrexate levels and renal function.
Fluorouracil (5-FU) Modulation (Colorectal Cancer): 200 mg/m2 IV over 2 hours, followed by 5-FU, or 20 mg/m2 IV bolus followed by 5-FU. Specific regimens vary widely.
Megaloblastic Anemia (Folate Deficiency): 1 mg/day IM/IV/PO. Max 15 mg/day.
Pyrimethamine/Trimethoprim Toxicity: 5-15 mg/day PO/IM/IV until hematologic parameters normalize.
๐Ÿ‘ถ

Pediatric Dosing

Neonatal: Not established for routine use, but used off-label for specific conditions (e.g., pyrimethamine toxicity) with careful dose adjustment.
Infant: Dosing for specific indications (e.g., pyrimethamine toxicity) is typically 5-15 mg/day PO/IM/IV. Methotrexate rescue doses are similar to adult mg/m2.
Child: Methotrexate rescue: 10-15 mg/m2 IV/IM/PO every 6 hours for 10 doses, starting 24 hours after methotrexate. Doses adjusted based on methotrexate levels. Pyrimethamine/Trimethoprim Toxicity: 5-15 mg/day PO/IM/IV.
Adolescent: Dosing generally follows adult mg/m2 guidelines for specific indications.
โš•๏ธ

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment recommended, but monitor methotrexate levels closely if used for rescue.
Moderate: No specific adjustment recommended, but monitor methotrexate levels closely if used for rescue. May require higher or prolonged leucovorin doses.
Severe: No specific adjustment recommended, but monitor methotrexate levels closely if used for rescue. May require higher or prolonged leucovorin doses. Consider continuous infusion.
Dialysis: Leucovorin is dialyzable. Methotrexate is dialyzable. If used for methotrexate rescue in dialysis patients, close monitoring of methotrexate levels and adjustment of leucovorin dose/duration is critical.

Hepatic Impairment:

Mild: Adjustment not generally required.
Moderate: Adjustment not generally required.
Severe: Adjustment not generally required. However, if hepatic impairment affects methotrexate elimination, leucovorin rescue may need to be prolonged.

Pharmacology

๐Ÿ”ฌ

Mechanism of Action

Leucovorin is a reduced form of folic acid (folinic acid) that does not require reduction by dihydrofolate reductase. It serves as a biochemical antidote to folic acid antagonists (e.g., methotrexate, pyrimethamine, trimethoprim) by providing the necessary cofactors for purine and pyrimidine synthesis, thus protecting healthy cells from the cytotoxic effects of these agents. When used with fluorouracil (5-FU), leucovorin enhances the cytotoxic effects of 5-FU by stabilizing the binding of fluorodeoxyuridine monophosphate (FdUMP) to thymidylate synthase, thereby inhibiting DNA synthesis and repair.
๐Ÿ“Š

Pharmacokinetics

Absorption:

Bioavailability: Oral bioavailability is variable, generally 90% for doses up to 25 mg, decreasing with higher doses due to saturable intestinal absorption. IV/IM bioavailability is 100%.
Tmax: Oral: 1.7 hours (for 5-formyl-THF); IV: 0.7 hours (for 5-methyl-THF).
FoodEffect: Food may delay absorption but does not significantly affect the extent of absorption.

Distribution:

Vd: Not available (complex distribution due to rapid metabolism).
ProteinBinding: Not significantly protein bound.
CnssPenetration: Limited penetration into the CNS, especially with standard doses. Higher doses or intrathecal administration may achieve therapeutic levels.

Elimination:

HalfLife: Leucovorin: ~0.7 hours; Active metabolite (5-methyl-THF): ~6.2 hours.
Clearance: Not precisely quantified, but rapid.
ExcretionRoute: Primarily renal (80-90%) and fecal (10-20%).
Unchanged: <1% (leucovorin); ~50% (5-methyl-THF) renally excreted.
โฑ๏ธ

Pharmacodynamics

OnsetOfAction: Rapid (minutes) after IV administration.
PeakEffect: Within 1 hour for leucovorin, several hours for active metabolite.
DurationOfAction: Several hours, primarily due to the longer half-life of the active metabolite.

Safety & Warnings

โš ๏ธ

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, which may include:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Seizures
* Severe dizziness or fainting

Other Possible Side Effects

Like all medications, this drug can cause side effects. Although many people do not experience any side effects or only have mild ones, it is essential to discuss any concerns with your doctor. If you experience any side effects that bother you or persist, contact your doctor for advice.

Please note that this list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
๐Ÿšจ

Seek Immediate Medical Attention If You Experience:

  • Severe diarrhea
  • Mouth sores or ulcers (mucositis)
  • Unusual bleeding or bruising
  • Signs of infection (fever, chills, sore throat)
  • Severe fatigue or weakness
  • Allergic reaction (rash, itching, swelling, dizziness, trouble breathing)
๐Ÿ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a type of anemia caused by a lack of vitamin B12.
If you have any stomach or bowel problems.

This list is not exhaustive, and it is crucial to discuss all your health conditions and medications with your doctor. Please inform your doctor and pharmacist about:
All prescription and over-the-counter (OTC) medications you are taking.
Any natural products or vitamins you are using.
All your health problems, including any medical conditions or concerns.

To ensure your safety, it is vital to verify that this medication can be taken with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
โš ๏ธ

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood work and laboratory tests should be conducted as directed by your doctor.

When used in combination with fluorouracil, this drug may increase the risk of side effects associated with fluorouracil, such as diarrhea, mouth irritation, and mouth sores. These side effects may occur more frequently, be more severe, and last longer. In older adults, the combination of this drug with fluorouracil has been linked to severe bowel problems, diarrhea, and dehydration, which can be fatal. If you have any questions or concerns, consult your doctor.

If you are 65 years or older, exercise caution when using this medication, as you may be more susceptible to side effects.

Before taking this drug, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Your doctor will discuss the potential benefits and risks of the medication to you and your baby.

Some formulations of this drug contain benzyl alcohol, which can be hazardous to newborns and infants. If possible, avoid using products that contain benzyl alcohol in these age groups, as high doses of benzyl alcohol can cause serious side effects, particularly when combined with other medications containing benzyl alcohol. Consult your doctor to determine which formulations contain benzyl alcohol and to discuss alternative options.
๐Ÿ†˜

Overdose Information

Overdose Symptoms:

  • Generally considered non-toxic in high doses, but may mask symptoms of pernicious anemia if used inappropriately.
  • Intrathecal overdose can be fatal (seizures, death).

What to Do:

In case of suspected overdose (especially intrathecal), seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Management is supportive.

Drug Interactions

๐Ÿ”ด

Major Interactions

  • Fluorouracil (5-FU): Leucovorin enhances the toxicity of 5-FU, including severe diarrhea, mucositis, and myelosuppression. This is often a desired effect in cancer therapy, but requires careful monitoring.
  • Methotrexate: Leucovorin is used to rescue cells from methotrexate toxicity, but if administered concurrently or inappropriately, it can antagonize the antineoplastic effect of methotrexate.
๐ŸŸก

Moderate Interactions

  • Phenytoin, Phenobarbital, Primidone: Leucovorin may decrease plasma concentrations of these anticonvulsants, potentially increasing seizure frequency. This is due to increased hepatic metabolism of anticonvulsants, possibly by increasing folate levels.
  • Co-trimoxazole (Trimethoprim/Sulfamethoxazole): Leucovorin can antagonize the antimicrobial effect of trimethoprim, which is a dihydrofolate reductase inhibitor. Used to mitigate toxicity, not for concurrent antimicrobial effect.
  • Pyrimethamine: Leucovorin can antagonize the antiparasitic effect of pyrimethamine. Used to mitigate toxicity, not for concurrent antiparasitic effect.

Monitoring

๐Ÿ”ฌ

Baseline Monitoring

Complete Blood Count (CBC) with differential

Rationale: To establish baseline hematologic status, especially important when used with myelosuppressive agents like methotrexate or 5-FU.

Timing: Prior to initiation of therapy.

Renal Function (Serum Creatinine, BUN)

Rationale: Renal impairment can affect methotrexate elimination, necessitating leucovorin dose adjustments.

Timing: Prior to initiation, especially for methotrexate rescue.

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, though leucovorin metabolism is not significantly affected by hepatic impairment, it's relevant for co-administered drugs.

Timing: Prior to initiation.

๐Ÿ“Š

Routine Monitoring

Methotrexate Plasma Levels

Frequency: As per protocol (e.g., 24, 48, 72 hours after methotrexate infusion)

Target: Varies by protocol (e.g., <0.1 ยตM at 48 hours, <0.05 ยตM at 72 hours)

Action Threshold: Levels above protocol-defined thresholds require increased leucovorin dose and/or prolonged administration.

Complete Blood Count (CBC) with differential

Frequency: Daily or every 2-3 days, especially when used with 5-FU or high-dose methotrexate.

Target: Maintain adequate neutrophil and platelet counts.

Action Threshold: Neutropenia (<1.5 x 10^9/L), thrombocytopenia (<100 x 10^9/L) may require dose modification of co-administered chemotherapy or supportive care.

Electrolytes (Potassium, Magnesium, Phosphate)

Frequency: Daily during high-dose methotrexate therapy.

Target: Within normal limits.

Action Threshold: Hypokalemia, hypomagnesemia, hypophosphatemia may occur with high-dose methotrexate and require correction.

Renal Function (Serum Creatinine, BUN)

Frequency: Daily during high-dose methotrexate therapy.

Target: Stable, within normal limits.

Action Threshold: Significant increase in creatinine may indicate methotrexate-induced renal toxicity, requiring aggressive hydration and leucovorin adjustment.

๐Ÿ‘๏ธ

Symptom Monitoring

  • Diarrhea (especially with 5-FU)
  • Mucositis/Stomatitis (especially with 5-FU)
  • Nausea and vomiting
  • Fatigue
  • Fever or signs of infection (due to myelosuppression)
  • Bleeding or bruising (due to thrombocytopenia)
  • Allergic reactions (rash, itching, swelling, difficulty breathing)

Special Patient Groups

๐Ÿคฐ

Pregnancy

Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Use only if clearly needed.

Trimester-Specific Risks:

First Trimester: Potential for fetal harm, especially if used in high doses or for prolonged periods. Risk of masking pernicious anemia if used inappropriately.
Second Trimester: Similar considerations as first trimester.
Third Trimester: Similar considerations as first trimester.
๐Ÿคฑ

Lactation

L3 (Moderately Safe). Leucovorin and its metabolites are excreted into breast milk. While generally considered safe due to its vitamin-like nature, caution is advised. The decision to breastfeed should consider the potential for infant exposure, the benefits of breastfeeding, and the mother's clinical need for leucovorin.

Infant Risk: Low risk, but monitor for any adverse effects. The amount transferred is likely small and unlikely to cause harm, especially if used for short durations or low doses. However, if used with cytotoxic agents, breastfeeding is generally contraindicated.
๐Ÿ‘ถ

Pediatric Use

Dosing is typically weight- or body surface area-based. Used for methotrexate rescue, megaloblastic anemia, and to mitigate toxicity of other folate antagonists. Close monitoring of methotrexate levels is crucial in pediatric methotrexate rescue. Safety and efficacy are established for appropriate indications.

๐Ÿ‘ด

Geriatric Use

No specific dose adjustments are generally required based on age alone. However, elderly patients may have reduced renal function, which could impact methotrexate elimination and thus the need for leucovorin rescue. Monitor renal function and methotrexate levels closely. Increased susceptibility to adverse effects of co-administered chemotherapy (e.g., 5-FU) may necessitate careful monitoring.

Clinical Information

๐Ÿ’Ž

Clinical Pearls

  • Leucovorin is NOT a chemotherapy drug; it is a rescue agent or modulator.
  • NEVER administer leucovorin intrathecally for methotrexate overdose; fatal reactions have occurred.
  • Always verify the dose and timing of leucovorin, especially in methotrexate rescue, as it is critical for efficacy and safety.
  • Oral leucovorin is generally effective for doses up to 25 mg; higher doses or patients with malabsorption may require parenteral administration.
  • When used with 5-FU, leucovorin enhances 5-FU's toxicity, which is the intended effect, but requires vigilant monitoring for severe diarrhea and mucositis.
  • Ensure adequate hydration and urinary alkalinization during high-dose methotrexate therapy to prevent renal toxicity and facilitate methotrexate excretion.
๐Ÿ”„

Alternative Therapies

  • Glucarpidase (Voraxaze): An enzyme that rapidly metabolizes methotrexate, used for delayed methotrexate elimination due to renal dysfunction. Not a direct alternative to leucovorin, but an alternative rescue strategy for methotrexate toxicity.
  • Folic Acid: While related, folic acid requires reduction by dihydrofolate reductase and cannot bypass the effects of folate antagonists like methotrexate. Not a substitute for leucovorin in rescue settings.
๐Ÿ’ฐ

Cost & Coverage

Average Cost: Varies widely by dose and manufacturer (e.g., $50 - $500+ per vial) per 350mg vial
Generic Available: Yes
Insurance Coverage: Typically covered by most medical and pharmacy benefit plans, especially for oncology indications. May fall under medical benefit for IV administration.
๐Ÿ“š

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Properly dispose of unused or expired medications by checking with your pharmacist for guidance, as some communities have drug take-back programs. Unless instructed to do so, avoid flushing medications down the toilet or pouring them down the drain. If you have questions about disposing of your medication, consult your pharmacist, who can also provide additional patient information leaflets for certain medications. If you have any concerns or questions about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred to ensure timely and effective treatment.